<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7948368/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Baseline characteristics of RA patients included in the discovery study</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">Characteristic</th>
   <th colspan="1" rowspan="1" id="0-1-.">Good-responders ( 
    <i>n</i> = 50) 
   </th>
   <th colspan="1" rowspan="1" id="0-2-.">Non-responders ( 
    <i>n</i> = 20) 
   </th>
   <th colspan="1" rowspan="1" id="0-3-.">
    <i>p</i> value 
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>Age, mean (SD)</td>
   <td>58.1 (13.1)</td>
   <td>55.3 (13)</td>
   <td>0.42 
    <sup>a</sup>
   </td>
  </tr>
  <tr>
   <td>Female, 
    <i>n</i> (%) 
   </td>
   <td>31 (62)</td>
   <td>15 (75)</td>
   <td>0.30 
    <sup>b</sup>
   </td>
  </tr>
  <tr>
   <td>Days on drug at outcome, median (IQR)</td>
   <td>113 (92, 147)</td>
   <td>109 (93, 147)</td>
   <td>0.74 
    <sup>c</sup>
   </td>
  </tr>
  <tr>
   <td>Baseline DAS28, mean (SD)</td>
   <td>5.07 (0.90)</td>
   <td>5.09 (0.90)</td>
   <td>0.93 
    <sup>a</sup>
   </td>
  </tr>
  <tr>
   <td>Concurrent DMARD therapy, 
    <i>n</i> (%) 
   </td>
   <td>46 (92)</td>
   <td>15 (75)</td>
   <td>0.06 
    <sup>b</sup>
   </td>
  </tr>
  <tr>
   <td>Swollen joint count, median (IQR)</td>
   <td>8 (5, 11)</td>
   <td>6 (3, 8)</td>
   <td>0.13 
    <sup>c</sup>
   </td>
  </tr>
  <tr>
   <td>Tender joint count, median (IQR)</td>
   <td>12 (6, 17)</td>
   <td>17 (9, 23)</td>
   <td>0.15 
    <sup>c</sup>
   </td>
  </tr>
  <tr>
   <td>Baseline HAQ score, median (IQR)</td>
   <td>1.5 (1, 2.13)</td>
   <td>1.8 (1.4, 2.3)</td>
   <td>0.21 
    <sup>c</sup>
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p>Patients were stratified by EULAR response at 3 months. All patients receiving concurrent DMARD therapy were receiving methotrexate. 
   <i>DAS28</i> 28-joint count disease activity score, 
   <i>DMARD</i> disease modifying anti-rheumatic drugs, 
   <i>HAQ</i> health assessment questionnaire, 
   <i>SD</i> standard deviation, 
   <i>IQR</i> interquartile range. 
   <i>p</i> value: 
   <sup>a</sup>two-sample 
   <i>t</i> test, 
   <sup>b</sup>chi-squared test, 
   <sup>c</sup>Wilcoxon rank-sum test 
  </p>
 </tfoot>
</table>
